| Company Name: |
GLP Pharma Standards
|
| Tel: |
+91 9866074638 |
| Email: |
info@glppharmastandards.com |
| Products Intro: |
Product Name:Efinaconazole Impurity (PDR)
CAS:2055912-03-1
Purity:98% Package:50 MG; 100 MG; 250 MG ; 25 MG
|
| Company Name: |
Beijing Comparison Pharmaceutical Technology Co., Ltd
|
| Tel: |
010-010-52878169 15801002657 |
| Email: |
sales@bjcomparison.com |
| Products Intro: |
Product Name:(2R,3R)-2-(2-fluoro-4-(4-methylenepiperidin-1-yl)phenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
CAS:2055912-03-1
Purity:≥98% Package:100mg
|
|
| | Efinaconazole Related Impurity 13 Basic information |
| Product Name: | Efinaconazole Related Impurity 13 | | Synonyms: | Efinaconazole Related Impurity 13;Efinaconazole Impurity 33;Efinaconazole Impurity 13;Efinaconazole Impurity;1-Piperidineethanol, α-[2-fluoro-4-(4-methylene-1-piperidinyl)phenyl]-β-methyl-4-methylene-α-(1H-1,2,4-triazol-1-ylmethyl)-, (αR,βR)-;(2R,3R)-2-(2-Fluoro-4-(4-methylenepiperidin-1-yl)phenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;Efinaconazole Impurity (PDR);(2R,3R)-2-(2-Fluoro-4-(4-methylenepiperidin-1-yl)phenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (Efinaconazole Impurity) | | CAS: | 2055912-03-1 | | MF: | C24H32FN5O | | MW: | 425.55 | | EINECS: | | | Product Categories: | | | Mol File: | 2055912-03-1.mol |  |
| | Efinaconazole Related Impurity 13 Chemical Properties |
| Boiling point | 610.2±65.0 °C(Predicted) | | density | 1.21±0.1 g/cm3(Predicted) | | pka | 12.25±0.29(Predicted) |
| | Efinaconazole Related Impurity 13 Usage And Synthesis |
| Uses | (2R,3R)-2-(2-Fluoro-4-(4-methylenepiperidin-1-yl)phenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol is an impurity of Efinaconazole (E435070), a topical antifungal for onychomycosis. |
| | Efinaconazole Related Impurity 13 Preparation Products And Raw materials |
|